Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send return request via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out navmed 6100 6 with our platform
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
Click ‘Get Form’ to open the navmed 6100 6 in the editor.
In Section 1, Clinical Information, enter the date, patient SSN, and full name (last, first, MI). Fill in the diagnosis and corresponding ICD-9 CM codes. Provide notes on the return to duty including findings and prognosis. Specify the proposed effective date of return to unrestricted duty and ensure the printed physician's name, signature, and date are included.
In Section 2, Patient Information, confirm that you have received full information regarding your return to duty. Sign and date this section to acknowledge understanding that your return is contingent upon approval by the MTF convening authority.
In Section 3, Patient Administration/Medical Evaluation Boards Official, ensure all actions are completed. The official will initial and date next to each entry including notifications and briefings. Include their printed name, signature, and date.
Finally, review all sections for accuracy before saving or exporting your completed form for submission.
Start using our platform today for free to streamline your document editing experience!
PLD is defined as a need for a service members skill or experience that justifies the continuance of that service member on active duty in a limited assignment; the service member may be retained on active duty for a specified period of time.
What is the difference between light duty and Limdu?
The main difference between light duty and limdu is that the former is a recommendation to you and your command, the latter is medical orders. If you are on 2 consecutive limdus without medical evidence that your condition will heal, then you are typically put on a medboard.
What is the abbreviated medical evaluation board report?
Abbreviated Medical Evaluation Board Report (AMEBR). A brief summary of the members medical condition limitations, and expected RTD date used to place a member on TLD.
What is permanent limited duty?
PLD is defined as a need for a service members skill or experience that justifies the continuance of that service member on active duty in a limited assignment; the service member may be retained on active duty for a specified period of time. Each case is individually considered.
What is the limited duty rule?
The limited duty rule essentially states that the landowner or operator has discharged its duty by taking certain appropriate actions, for example protective netting.
TLD is authorized locally, and may not exceed 364 days of non-deployability, by the convening authority (CA) responsible for the military treatment facility (MTF) initiating TLD. The maximum total TLD authorized is 12 months unless otherwise approved by NAVPERSCOM (PERS-454).
How long can you be on Limdu?
Similarly, if a provider knew a Sailors or Marines recovery would be longer than 180 days, they couldnt set a realistic recovery period because of the maximum 180 day limit. This required an extra administrative step to review and extend the LIMDU period at the end of the 180 day limit.
Is an LDO a line officer?
LDOs in the Surface, Nuclear/Subsurface, Aviation, General Line, and Information Warfare are Line officers; LDOs in the Staff series are Staff Corps officers.
medical officer
ABBREVIATED MEDICAL EVALUATION BOARD REPORT
NAVMED 6100/5 (Rev. 08-2004). PREVIOUS EDITIONS OBSOLETE. ROUTING: Original to Patient Health Record; copies to Patient, Parent Command, PSD,. MEBR Case File
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.... Read more...Read less
